recombinant human mouse rat activin a (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
96
Structured Review
R&D Systems
recombinant human mouse rat activin a
Recombinant Human Mouse Rat Activin A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 589 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+activin+a/Recombinant+Human%2FMouse%2FRat+Activin+A+Protein/pmc13120857-25-22-27
Average 96 stars, based on 589 article reviews
Recombinant Human Mouse Rat Activin A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 589 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+activin+a/Recombinant+Human%2FMouse%2FRat+Activin+A+Protein/pmc13120857-25-22-27
Average 96 stars, based on 589 article reviews
recombinant human mouse rat activin a - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Recombinant:Article Title: Chronic cerebral hypoperfusion induces venous dysfunction via EPAS1 regulation in mice. Article Snippet: To seed for endothelial differentiation, H9 were dissociated with accutase (Gibco, A1110501) into single cells, then plated onto Matrigel-coated plates at a density of 50,000 cells/cm2 in mTeSR1 medium supplemented with 5 μMROCK inhibitor, Y-27632 (STEMCELL Technologies, 72304). .. 24 h later, H9 cells were induced towards the mid-primitive streak differentiation pathway with 40 ng/ml recombinant human BMP-4 (R&D Systems, 314-BP/CF), 6 μM CHIR99021 (Sigma-Aldrich, SML1046), 4 μg/ml recombinant human FGF2 (R&D Systems, 233-FB/CF), PIK-90 (SigmaAldrich, 528117), Article Title: PAVR: High-Resolution Cellular Imaging via a Physics-Aware Volumetric Reconstruction Framework Article Snippet: MR90-IV (WiCell Research Institute) was maintained in mTeSR1 medium (Stem Cell Technologies) and induced for cardiac differentiation as previously described . .. Briefly, hiPSCs were treated with 100 μg/mL Article Title: Method for producing pluripotent stem cells Article Snippet: On day 1 of the culture, medium exchange was performed with a MEF-conditioned medium containing bFGF at a final concentration of 20 ng/mL. (Step 2-A: Induction of Differentiation into Ectoderm Cells) For the cells prepared in Step 1 of Example 7, medium exchange was performed on day 2 of the culture with KnockOut-DMEM (Thermo Fisher Scientific K.K.) containing knockout serum replacement (Thermo Fisher Scientific K.K.) at a final concentration of 10%, Noggin (R&D Systems, Inc.) at a final concentration of 500 ng/mL, and SB431542 (Tocris Bioscience) at a final concentration of 10 μM. .. Medium exchange was performed using the same medium on day 3 of the culture, and thereby an ectoderm cell population could be obtained on day 4 of the culture. (Step 2-B: Induction of Differentiation into Mesoderm Cells) For the cells prepared in Step 1 of Example 7, medium exchange was performed on day 2 of the culture with an RPMI-B27 (Thermo Fisher Scientific K.K.) medium to which Article Title: HYPER-Net: Physics-Conditioned Self-Supervised Reconstruction for Fourier Light-Field Microscopy Article Snippet: MR90-IV (WiCell Research Institute) was maintained in mTeSR1 medium (Stem Cell Technologies) and induced for cardiac differentiation as previously described . .. Briefly, hiPSCs were treated with 100 ng/ml Article Title: Mechano-activated chondroprogenitors (MACs) drive intrinsic cartilage repair; a process that is arrested in osteoarthritis Article Snippet: .. Human recombinant FGF2 was purchased from Peprotech EC Ltd. Article Title: Chronic cerebral hypoperfusion induces venous dysfunction via EPAS1 regulation in mice Article Snippet: To seed for endothelial differentiation, H9 were dissociated with accutase (Gibco, A1110501) into single cells, then plated onto Matrigel-coated plates at a density of 50,000 cells/cm 2 in mTeSR1 medium supplemented with 5 μM ROCK inhibitor, Y-27632 (STEMCELL Technologies, 72304). .. 24 h later, H9 cells were induced towards the mid-primitive streak differentiation pathway with 40 ng/ml recombinant human BMP-4 (R&D Systems, 314-BP/CF), 6 μM CHIR99021 (Sigma-Aldrich, SML1046), 4 μg/ml recombinant human FGF2 (R&D Systems, 233-FB/CF), PIK-90 (Sigma-Aldrich, 528117), Article Title: Universal donor cells and related methods Article Snippet: .. : hESC aggregates; XF HA: DMEM/F12 containing GlutaMAX, supplemented with 10% v/v of Xeno-free KnockOut Serum Replacement, 1% v/v non-essential amino acids, 1% v/v penicillin/streptomycin (all from Life Technologies), 10 ng/mL heregulin-1β (Peprotech) and 10 ng/mL activin A (R&D Systems); SP: StemPro ® hESC SFM (Life Technologies); r0.2FBS: RPMI 1640 (Mediatech); 0.2% FBS (HyClone), 1x GlutaMAX-1 (Life Technologies), 1% v/v penicillin/streptomycin; ITS: Insulin-Transferrin-Selenium (Life Technologies) diluted 1:5000 or 1:1000; A100: 100 ng/mL Article Title: Resf1 is required for proper placental development and configuration of trophoblast cell-specific heterochromatin Article Snippet: .. CDM was prepared with Neurobasal medium (Gibco, 21103-049) and DMEM high glucose (Sigma, D6429), supplemented with N2 supplement (1×; Gibco, 17502-048), B27 supplement (1×; Gibco, 12587-610), penicillin– streptomycin (1×), 2-mercaptoethanol (150 μM; e-Nacalai), bovine serum albumin (0.05%), KnockOut Serum Replacement (1%; Gibco), recombinant mouse basic fibroblast growth factor (50 ng/ml; Wako, 450-33), Modification:Article Title: Chronic cerebral hypoperfusion induces venous dysfunction via EPAS1 regulation in mice. Article Snippet: To seed for endothelial differentiation, H9 were dissociated with accutase (Gibco, A1110501) into single cells, then plated onto Matrigel-coated plates at a density of 50,000 cells/cm2 in mTeSR1 medium supplemented with 5 μMROCK inhibitor, Y-27632 (STEMCELL Technologies, 72304). .. 24 h later, H9 cells were induced towards the mid-primitive streak differentiation pathway with 40 ng/ml recombinant human BMP-4 (R&D Systems, 314-BP/CF), 6 μM CHIR99021 (Sigma-Aldrich, SML1046), 4 μg/ml recombinant human FGF2 (R&D Systems, 233-FB/CF), PIK-90 (SigmaAldrich, 528117), Article Title: Chronic cerebral hypoperfusion induces venous dysfunction via EPAS1 regulation in mice Article Snippet: To seed for endothelial differentiation, H9 were dissociated with accutase (Gibco, A1110501) into single cells, then plated onto Matrigel-coated plates at a density of 50,000 cells/cm 2 in mTeSR1 medium supplemented with 5 μM ROCK inhibitor, Y-27632 (STEMCELL Technologies, 72304). .. 24 h later, H9 cells were induced towards the mid-primitive streak differentiation pathway with 40 ng/ml recombinant human BMP-4 (R&D Systems, 314-BP/CF), 6 μM CHIR99021 (Sigma-Aldrich, SML1046), 4 μg/ml recombinant human FGF2 (R&D Systems, 233-FB/CF), PIK-90 (Sigma-Aldrich, 528117), Concentration Assay:Article Title: Method for producing pluripotent stem cells Article Snippet: On day 1 of the culture, medium exchange was performed with a MEF-conditioned medium containing bFGF at a final concentration of 20 ng/mL. (Step 2-A: Induction of Differentiation into Ectoderm Cells) For the cells prepared in Step 1 of Example 7, medium exchange was performed on day 2 of the culture with KnockOut-DMEM (Thermo Fisher Scientific K.K.) containing knockout serum replacement (Thermo Fisher Scientific K.K.) at a final concentration of 10%, Noggin (R&D Systems, Inc.) at a final concentration of 500 ng/mL, and SB431542 (Tocris Bioscience) at a final concentration of 10 μM. .. Medium exchange was performed using the same medium on day 3 of the culture, and thereby an ectoderm cell population could be obtained on day 4 of the culture. (Step 2-B: Induction of Differentiation into Mesoderm Cells) For the cells prepared in Step 1 of Example 7, medium exchange was performed on day 2 of the culture with an RPMI-B27 (Thermo Fisher Scientific K.K.) medium to which Knock-Out:Article Title: Universal donor cells and related methods Article Snippet: .. : hESC aggregates; XF HA: DMEM/F12 containing GlutaMAX, supplemented with 10% v/v of Xeno-free KnockOut Serum Replacement, 1% v/v non-essential amino acids, 1% v/v penicillin/streptomycin (all from Life Technologies), 10 ng/mL heregulin-1β (Peprotech) and 10 ng/mL activin A (R&D Systems); SP: StemPro ® hESC SFM (Life Technologies); r0.2FBS: RPMI 1640 (Mediatech); 0.2% FBS (HyClone), 1x GlutaMAX-1 (Life Technologies), 1% v/v penicillin/streptomycin; ITS: Insulin-Transferrin-Selenium (Life Technologies) diluted 1:5000 or 1:1000; A100: 100 ng/mL Article Title: Resf1 is required for proper placental development and configuration of trophoblast cell-specific heterochromatin Article Snippet: .. CDM was prepared with Neurobasal medium (Gibco, 21103-049) and DMEM high glucose (Sigma, D6429), supplemented with N2 supplement (1×; Gibco, 17502-048), B27 supplement (1×; Gibco, 12587-610), penicillin– streptomycin (1×), 2-mercaptoethanol (150 μM; e-Nacalai), bovine serum albumin (0.05%), KnockOut Serum Replacement (1%; Gibco), recombinant mouse basic fibroblast growth factor (50 ng/ml; Wako, 450-33), |